Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bio-Rad Laboratories, Inc. Class A Common Stock (NY:BIO)

295.73 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Jul 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 295.73
Bid (Size) 118.30 (80)
Ask (Size) 470.21 (40)
Prev. Close 295.73
Today's Range 295.73 - 295.73
52wk Range 236.73 - 343.12
Shares Outstanding 22,140,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Bio-Rad vs. Charles River Labs: Which Medical Research Stock Is a Better Buy in 2026? ↗
Bio-Rad posts robust margins and liquidity, while Charles River leads in global drug discovery services. Explore how their fundamentals stack up for investors. 
Via The Motley Fool
News headline image
Why Elliott Sees Hidden Billions Inside Bio-Rad Laboratories ↗
Elliott Management builds a stake in Bio-Rad (NYSE: BIO) to push for better performance, but family voting control could pose a hurdle. 
Via Benzinga

Performance

YTD
-3.1%
-3.1%
1 Month
+2.2%
+2.2%
3 Month
-0.1%
-0.1%
6 Month
-7.1%
-7.1%
1 Year
+19.6%
+19.6%

More News

Read More
News headline image
Bio-Rad to Participate in Upcoming Investor Conferences
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Bio-Rad (BIO) Q2 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Bio-Rad Q1 2026 Revenue Misses Estimates, Outlook Cut as NYSE:BIO Faces Cautious Trading ↗
Via Chartmill
Bio-Rad Laboratories (NYSE:BIO) Stock Plummets 12% After Q4 Earnings Miss and Weak 2026 Outlook ↗
Via Chartmill
Topics Earnings
News headline image
Earnings Scheduled For October 29, 2025 ↗
Via Benzinga
News headline image
Bio-Rad (BIO) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
Topics World Trade
News headline image
Bio-Rad Reports First-Quarter 2026 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Bio-Rad to Report First-Quarter 2026 Financial Results on Thursday, April 30, 2026
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Bio-Rad (BIO) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Bio-Rad Reports Fourth-Quarter and Full-Year 2025 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Bio-Rad to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 12, 2026
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan's 44th Annual Healthcare Conference
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Why a Fund Trimmed a $41 Million CompoSecure Stake Amid a 47% Stock Run ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why a Fund Cut $4 Million of Payoneer Stock Despite Record Revenues ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why Bio-Rad Laboratories Stock Slipped by More Than 3% on Thursday ↗
Via The Motley Fool
Topics Supply Chain
News headline image
Bio-Rad Reports Third-Quarter 2025 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Bio-Rad to Report Third Quarter 2025 Financial Results on Wednesday, October 29, 2025
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Thermo Fisher Scientific Soars on Strategic Wins, Market Optimism
Via MarketMinute
Topics Artificial Intelligence Economy Government
News headline image
Bio-Rad Laboratories, Inc. Co-Founder and Director Emeritus Alice Schwartz Passes Away
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Bio-Rad's Management to Participate in Upcoming Investor Conferences
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Bio-Rad (BIO) Q2 EPS Jumps 51% ↗
Via The Motley Fool
News headline image
Bio-Rad Laboratories Analysts Raise Their Forecasts After Better-Than-Expected Q2 Earnings ↗
Via Benzinga
News headline image
Monolithic Power Systems, Workiva, Interface, AppFolio And Other Big Stocks Moving Higher On Friday ↗
Via Benzinga

Frequently Asked Questions

Is Bio-Rad Laboratories, Inc. Class A Common Stock publicly traded?
Yes, Bio-Rad Laboratories, Inc. Class A Common Stock is publicly traded.
What exchange does Bio-Rad Laboratories, Inc. Class A Common Stock trade on?
Bio-Rad Laboratories, Inc. Class A Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Bio-Rad Laboratories, Inc. Class A Common Stock?
The ticker symbol for Bio-Rad Laboratories, Inc. Class A Common Stock is BIO on the New York Stock Exchange
What is the current price of Bio-Rad Laboratories, Inc. Class A Common Stock?
The current price of Bio-Rad Laboratories, Inc. Class A Common Stock is 295.73
When was Bio-Rad Laboratories, Inc. Class A Common Stock last traded?
The last trade of Bio-Rad Laboratories, Inc. Class A Common Stock was at 07/15/26 07:00 PM ET
What is the market capitalization of Bio-Rad Laboratories, Inc. Class A Common Stock?
The market capitalization of Bio-Rad Laboratories, Inc. Class A Common Stock is 6.55B
How many shares of Bio-Rad Laboratories, Inc. Class A Common Stock are outstanding?
Bio-Rad Laboratories, Inc. Class A Common Stock has 7B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.